急性肾损伤
病危
肾功能
多元统计
医学
多元分析
重症监护医学
回顾性队列研究
多中心研究
内科学
计算机科学
机器学习
随机对照试验
作者
Jiaxi Lin,Lihe Liu,Shiqi Zhu,Jingwen Gao,Lu Liu,Hao Hong,Yao Wei,Jing Yang,Xiaolin Liu,Rui Li,Jinzhou Zhu
出处
期刊:Ndt Plus
[Oxford University Press]
日期:2025-05-06
卷期号:18 (6): sfaf142-sfaf142
被引量:1
摘要
ABSTRACT Background Acute kidney injury (AKI) exhibits considerable heterogeneity. The objective of the current study was to identify AKI subphenotypes in intensive care unit (ICU) patients using multivariate renal function trajectories. Methods A retrospective study was performed on two independent datasets: the MIMIC-IV and eICU datasets. Using group-based multivariate trajectory modelling (GBMTM), we identified AKI subphenotypes based on trajectories of estimated glomerular filtration rate (eGFR) and urine output (UO). Multivariate Cox regression was applied to quantify the risk associated with the AKI subphenotype concerning clinical outcomes. Results Our study enrolled a total of 17 113 ICU patients diagnosed with AKI, revealing four AKI subphenotypes via GBMTM. Subphenotype 1, characterized by a swift decrease in eGFR coupled with a gradual increase in UO, exhibited the highest mortality rates (24% in the MIMIC-IV cohort, 20% in the eICU cohort). Conversely, subphenotype 4, featuring a marked increase in eGFR alongside stable UO levels, demonstrated the most favourable prognosis (15% mortality in the MIMIC-IV cohort, 8% in the eICU cohort). Subphenotypes 2 and 3 shared similar eGFR trends, however, subphenotype 2 experienced a rapid decrease in UO, whereas subphenotype 3 maintained stability in this regard. Across both datasets, subphenotype 4 showed a significantly reduced risk of mortality compared with subphenotype 1 {hazard ratio [HR] 0.72 [95% confidence interval (CI) 0.60–0.81], P < .001 in the MIMIC-IV cohort; HR 0.49 [95% CI 0.37–0.64], P < .001 in the eICU cohort}. Conclusions This study differentiated and stratified AKI subphenotypes among ICU patients by leveraging multivariate renal function trajectories, laying a foundation for personalized therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI